No-response at mpMRI after neoadjuvant pembrolizumab is a proxy of adverse pathological and oncological outcomes in patients treated with radical cystectomy: Interim results from the PURE01 study
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-07-01
|
| Series: | European Urology Open Science |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666168320331323 |
| _version_ | 1819074911699730432 |
|---|---|
| author | M. Bandini E. Zaffuto S. Scuderi F. Pederzoli L. Marandino D. Raggi F. Barletta G. Gandaglia N. Fossati G. Burgio M. Moschini S. Zamboni L. Afferi S. Comara A. Briganti F. Montorsi R. Colombo A. Necchi A. Gallina |
| author_facet | M. Bandini E. Zaffuto S. Scuderi F. Pederzoli L. Marandino D. Raggi F. Barletta G. Gandaglia N. Fossati G. Burgio M. Moschini S. Zamboni L. Afferi S. Comara A. Briganti F. Montorsi R. Colombo A. Necchi A. Gallina |
| author_sort | M. Bandini |
| collection | DOAJ |
| first_indexed | 2024-12-21T18:17:02Z |
| format | Article |
| id | doaj.art-048d690cb3f544c2b0aec3247eafd0e9 |
| institution | Directory Open Access Journal |
| issn | 2666-1683 |
| language | English |
| last_indexed | 2024-12-21T18:17:02Z |
| publishDate | 2020-07-01 |
| publisher | Elsevier |
| record_format | Article |
| series | European Urology Open Science |
| spelling | doaj.art-048d690cb3f544c2b0aec3247eafd0e92022-12-21T18:54:38ZengElsevierEuropean Urology Open Science2666-16832020-07-0119e823No-response at mpMRI after neoadjuvant pembrolizumab is a proxy of adverse pathological and oncological outcomes in patients treated with radical cystectomy: Interim results from the PURE01 studyM. BandiniE. ZaffutoS. ScuderiF. PederzoliL. MarandinoD. RaggiF. BarlettaG. GandagliaN. FossatiG. BurgioM. MoschiniS. ZamboniL. AfferiS. ComaraA. BrigantiF. MontorsiR. ColomboA. NecchiA. Gallinahttp://www.sciencedirect.com/science/article/pii/S2666168320331323 |
| spellingShingle | M. Bandini E. Zaffuto S. Scuderi F. Pederzoli L. Marandino D. Raggi F. Barletta G. Gandaglia N. Fossati G. Burgio M. Moschini S. Zamboni L. Afferi S. Comara A. Briganti F. Montorsi R. Colombo A. Necchi A. Gallina No-response at mpMRI after neoadjuvant pembrolizumab is a proxy of adverse pathological and oncological outcomes in patients treated with radical cystectomy: Interim results from the PURE01 study European Urology Open Science |
| title | No-response at mpMRI after neoadjuvant pembrolizumab is a proxy of adverse pathological and oncological outcomes in patients treated with radical cystectomy: Interim results from the PURE01 study |
| title_full | No-response at mpMRI after neoadjuvant pembrolizumab is a proxy of adverse pathological and oncological outcomes in patients treated with radical cystectomy: Interim results from the PURE01 study |
| title_fullStr | No-response at mpMRI after neoadjuvant pembrolizumab is a proxy of adverse pathological and oncological outcomes in patients treated with radical cystectomy: Interim results from the PURE01 study |
| title_full_unstemmed | No-response at mpMRI after neoadjuvant pembrolizumab is a proxy of adverse pathological and oncological outcomes in patients treated with radical cystectomy: Interim results from the PURE01 study |
| title_short | No-response at mpMRI after neoadjuvant pembrolizumab is a proxy of adverse pathological and oncological outcomes in patients treated with radical cystectomy: Interim results from the PURE01 study |
| title_sort | no response at mpmri after neoadjuvant pembrolizumab is a proxy of adverse pathological and oncological outcomes in patients treated with radical cystectomy interim results from the pure01 study |
| url | http://www.sciencedirect.com/science/article/pii/S2666168320331323 |
| work_keys_str_mv | AT mbandini noresponseatmpmriafterneoadjuvantpembrolizumabisaproxyofadversepathologicalandoncologicaloutcomesinpatientstreatedwithradicalcystectomyinterimresultsfromthepure01study AT ezaffuto noresponseatmpmriafterneoadjuvantpembrolizumabisaproxyofadversepathologicalandoncologicaloutcomesinpatientstreatedwithradicalcystectomyinterimresultsfromthepure01study AT sscuderi noresponseatmpmriafterneoadjuvantpembrolizumabisaproxyofadversepathologicalandoncologicaloutcomesinpatientstreatedwithradicalcystectomyinterimresultsfromthepure01study AT fpederzoli noresponseatmpmriafterneoadjuvantpembrolizumabisaproxyofadversepathologicalandoncologicaloutcomesinpatientstreatedwithradicalcystectomyinterimresultsfromthepure01study AT lmarandino noresponseatmpmriafterneoadjuvantpembrolizumabisaproxyofadversepathologicalandoncologicaloutcomesinpatientstreatedwithradicalcystectomyinterimresultsfromthepure01study AT draggi noresponseatmpmriafterneoadjuvantpembrolizumabisaproxyofadversepathologicalandoncologicaloutcomesinpatientstreatedwithradicalcystectomyinterimresultsfromthepure01study AT fbarletta noresponseatmpmriafterneoadjuvantpembrolizumabisaproxyofadversepathologicalandoncologicaloutcomesinpatientstreatedwithradicalcystectomyinterimresultsfromthepure01study AT ggandaglia noresponseatmpmriafterneoadjuvantpembrolizumabisaproxyofadversepathologicalandoncologicaloutcomesinpatientstreatedwithradicalcystectomyinterimresultsfromthepure01study AT nfossati noresponseatmpmriafterneoadjuvantpembrolizumabisaproxyofadversepathologicalandoncologicaloutcomesinpatientstreatedwithradicalcystectomyinterimresultsfromthepure01study AT gburgio noresponseatmpmriafterneoadjuvantpembrolizumabisaproxyofadversepathologicalandoncologicaloutcomesinpatientstreatedwithradicalcystectomyinterimresultsfromthepure01study AT mmoschini noresponseatmpmriafterneoadjuvantpembrolizumabisaproxyofadversepathologicalandoncologicaloutcomesinpatientstreatedwithradicalcystectomyinterimresultsfromthepure01study AT szamboni noresponseatmpmriafterneoadjuvantpembrolizumabisaproxyofadversepathologicalandoncologicaloutcomesinpatientstreatedwithradicalcystectomyinterimresultsfromthepure01study AT lafferi noresponseatmpmriafterneoadjuvantpembrolizumabisaproxyofadversepathologicalandoncologicaloutcomesinpatientstreatedwithradicalcystectomyinterimresultsfromthepure01study AT scomara noresponseatmpmriafterneoadjuvantpembrolizumabisaproxyofadversepathologicalandoncologicaloutcomesinpatientstreatedwithradicalcystectomyinterimresultsfromthepure01study AT abriganti noresponseatmpmriafterneoadjuvantpembrolizumabisaproxyofadversepathologicalandoncologicaloutcomesinpatientstreatedwithradicalcystectomyinterimresultsfromthepure01study AT fmontorsi noresponseatmpmriafterneoadjuvantpembrolizumabisaproxyofadversepathologicalandoncologicaloutcomesinpatientstreatedwithradicalcystectomyinterimresultsfromthepure01study AT rcolombo noresponseatmpmriafterneoadjuvantpembrolizumabisaproxyofadversepathologicalandoncologicaloutcomesinpatientstreatedwithradicalcystectomyinterimresultsfromthepure01study AT anecchi noresponseatmpmriafterneoadjuvantpembrolizumabisaproxyofadversepathologicalandoncologicaloutcomesinpatientstreatedwithradicalcystectomyinterimresultsfromthepure01study AT agallina noresponseatmpmriafterneoadjuvantpembrolizumabisaproxyofadversepathologicalandoncologicaloutcomesinpatientstreatedwithradicalcystectomyinterimresultsfromthepure01study |